Angsana Provides Tests for Allergen Sensitization Specific for Asian Population
Reliance on Thermo Fisher Scientific Technology Will Ensure Improved Diagnostic Efficiency Which May Aid Better Allergy Management
(firmenpresse) - SINGAPORE -- (Marketwired) -- 10/31/16 -- today announced that it will provide tests for allergen sensitization specific for the Asian population using industry leading technology by . The tests will be based on ImmunoCAP technology and performed on Phadia Laboratory Systems.
Allergy constitutes a major health concern in both adolescents and adults. While many allergens are common across populations, there has been increased recognition of differences in the prevalence and morbidity of atopic diseases among different ethnic groups and across different geographic regions. Factors such as genetics, environmental exposure, diet and social behavior appear to contribute.
is seeking to define and validate specific tests for allergen sensitization that are suited to local needs. ImmunoCAP technology is well known for its high specificity and sensitivity, quantitative results, high quality and a comprehensive menu of allergens and allergen components.
" is committed to deliver high-performance and affordable molecular diagnostic services to meet the health demand of Asian population. We are excited to work with and its technology to help us expand our service capabilities to better address this major public health concern," said Dr. Chris Tan, Chief Executive Officer of . "With the rising incidence of atopic diseases, particularly among younger children, it is important to better understand the regional and ethnic differences in Asian countries," said Dr. Richard Choy, Chief Scientific Officer and managing director of Hong Kong laboratory. "Through collaboration with local medical experts and healthcare providers, aims to provide a testing solution for Asia, in order to help improve the diagnosis efficiency and aid better allergy management."
"We''re pleased that recognizes our quality and expertise and we are pleased that our technology can be used to support their efforts," said [Stefan Wolf], president, ImmunoDiagnostics, . "Providing tests for allergen sensitization for the Asian population will help to enable healthcare professionals to have a better understanding of the symptoms of their patients."
has recently acquired , a Singapore-based private laboratory with over 10-year experience serving in the allergy testing business. "The acquisition enables us to combine the existing tests and dedicated expertise from Allergy Laboratory with the range of premium molecular assays from , providing an expanded, high-quality diagnostic services under the CAP-accredited environment" said Dr. Chris Tan from .
Company Logo
, a multi-national company, specializes in developing premium molecular diagnostic assays, serving four medical areas that have the largest impact in Asian population: allergy and molecular allergology, fetal maternal health, molecular oncology and pharmacogenetics. Through analysis of medical conditions at a molecular level, combined with clinical consultations by board-certified medical specialists, empowers clinicians and patients to make better informed clinical decisions and improve the quality of patient care. Strategically located in the center of Asia, operated from CAP-accredited laboratories in both Singapore and Hong Kong and a business office in Malaysia, is dedicated to serving the Asian healthcare community with fast and more affordable services within easy reach. For more information, visit .
MEDIA CONTACT:
Angsana Molecular & Diagnostics Laboratory Pte Ltd
Name: Clara Fu
Sales & Marketing Manager
Phone: (852) 2793 0782
Email:
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 31.10.2016 - 21:00 Uhr
Sprache: Deutsch
News-ID 1466997
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
SINGAPORE
Phone:
Kategorie:
Alternative
Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:
Diese Pressemitteilung wurde bisher 463 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Angsana Provides Tests for Allergen Sensitization Specific for Asian Population
"
steht unter der journalistisch-redaktionellen Verantwortung von
Angsana Molecular & Diagnostics Laboratory (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
